Shanghai Pharmaceuticals Holding Co Ltd Strategic Asset Allocation Index
Shanghai Pharmaceuticals Holding Co Ltd strategic asset allocation index. Shanghai Pharmaceuticals Holding Co Ltd (601607) has a Strategic Asset Allocation Index of 21.3% as of June 2023. Strategic assets (PP&E of CN¥16.84 Billion plus long-term investments of CN¥-) total CN¥16.84 Billion, measured against net assets of CN¥78.94 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check Shanghai Pharmaceuticals Holding Co Ltd tangible net worth ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Shanghai Pharmaceuticals Holding Co Ltd (2000–2021)
Strategic asset allocation index of Shanghai Pharmaceuticals Holding Co Ltd from 2000 to 2021. This chart shows how Shanghai Pharmaceuticals Holding Co Ltd's Strategic Asset Allocation Index has evolved across 22 annual periods from 2000 to 2021. As of June 2023, the index stands at 21.3%, representing strategic assets of CN¥16.84 Billion against net assets of CN¥78.94 Billion CNY.
Shanghai Pharmaceuticals Holding Co Ltd Strategic Asset Allocation Index by Year (2000–2021)
Shanghai Pharmaceuticals Holding Co Ltd strategic asset allocation index by year from 2000 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Shanghai Pharmaceuticals Holding Co Ltd from 2000 to 2021, covering 22 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see how much is Shanghai Pharmaceuticals Holding Co Ltd worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 26.7% | CN¥15.79 Billion | CN¥15.79 Billion | CN¥- | CN¥59.07 Billion | ▲ +0.0 pp |
| 2020 | 26.7% | CN¥14.63 Billion | CN¥14.63 Billion | CN¥- | CN¥54.74 Billion | ▼ -10.9 pp |
| 2019 | 37.6% | CN¥18.56 Billion | CN¥13.13 Billion | CN¥5.43 Billion | CN¥49.39 Billion | ▲ +4.7 pp |
| 2018 | 32.8% | CN¥15.25 Billion | CN¥10.60 Billion | CN¥4.65 Billion | CN¥46.43 Billion | ▼ -2.2 pp |
| 2017 | 35.0% | CN¥13.90 Billion | CN¥9.10 Billion | CN¥4.80 Billion | CN¥39.68 Billion | ▲ +3.9 pp |
| 2016 | 31.1% | CN¥11.46 Billion | CN¥6.97 Billion | CN¥4.50 Billion | CN¥36.83 Billion | ▲ +1.5 pp |
| 2015 | 29.6% | CN¥10.01 Billion | CN¥6.09 Billion | CN¥3.92 Billion | CN¥33.81 Billion | ▲ +13.5 pp |
| 2014 | 16.1% | CN¥4.99 Billion | CN¥4.99 Billion | CN¥- | CN¥31.10 Billion | ▼ -0.5 pp |
| 2013 | 16.6% | CN¥4.81 Billion | CN¥4.81 Billion | CN¥- | CN¥29.00 Billion | ▲ +1.2 pp |
| 2012 | 15.4% | CN¥4.26 Billion | CN¥4.26 Billion | CN¥- | CN¥27.70 Billion | ▼ -0.2 pp |
| 2011 | 15.6% | CN¥4.04 Billion | CN¥4.04 Billion | CN¥- | CN¥25.98 Billion | ▼ -19.0 pp |
| 2010 | 34.5% | CN¥4.10 Billion | CN¥4.10 Billion | CN¥- | CN¥11.88 Billion | ▼ -3.9 pp |
| 2009 | 38.4% | CN¥892.38 Million | CN¥892.38 Million | CN¥- | CN¥2.32 Billion | ▼ -5.3 pp |
| 2008 | 43.7% | CN¥913.51 Million | CN¥913.51 Million | CN¥- | CN¥2.09 Billion | ▼ -12.4 pp |
| 2007 | 56.2% | CN¥1.10 Billion | CN¥1.10 Billion | CN¥- | CN¥1.96 Billion | ▼ -18.4 pp |
| 2006 | 74.5% | CN¥1.54 Billion | CN¥1.54 Billion | CN¥- | CN¥2.07 Billion | ▲ +21.7 pp |
| 2005 | 52.8% | CN¥1.06 Billion | CN¥1.06 Billion | CN¥- | CN¥2.01 Billion | ▲ +2.7 pp |
| 2004 | 50.1% | CN¥1.03 Billion | CN¥1.03 Billion | CN¥- | CN¥2.06 Billion | ▼ -0.5 pp |
| 2003 | 50.6% | CN¥1.08 Billion | CN¥1.08 Billion | CN¥- | CN¥2.13 Billion | ▼ -2.3 pp |
| 2002 | 52.9% | CN¥1.06 Billion | CN¥1.06 Billion | CN¥- | CN¥2.00 Billion | ▲ +14.5 pp |
| 2001 | 38.4% | CN¥698.35 Million | CN¥698.35 Million | CN¥- | CN¥1.82 Billion | ▼ -20.2 pp |
| 2000 | 58.6% | CN¥577.19 Million | CN¥577.19 Million | CN¥- | CN¥985.30 Million | — |